Cantourage Group

Philip Schetter, a member of the executive board of Cantourage Group, has accepted the grant of 25,000 stock options under the employee participation program Cantourage Aktienoptionsplan 2023. Exercise of the options is subject to a performance target and a four‑year vesting period; the exercise price is determined by the volume‑weighted average closing auction price on Xetra over the ten trading days prior to grant. The transaction took place off‑exchange on 4 June 2026. » Altro su de.investing.com

Cantourage Group has confirmed that board member Monique Jaqqam has accepted 25,000 stock options under the employee participation program 'Cantourage Aktienoptionsplan 2023'. The exercise of the options is subject to the achievement of a performance target and a four-year vesting period. The exercise price corresponds to the volume-weighted average price of the last ten Xetra trading days prior to the respective grant date. The transaction was executed on 4 June 2026 off-exchange. » Altro su de.investing.com

Cantourage reports a revenue increase of 11.0% versus Q4 2025 to EUR 20.6m for Q1 2026 and an EBITDA of EUR 2.2m with an EBITDA margin of 10.6%. Drivers are a focus on premium products, international expansion with strong growth in the UK (41.3% of revenue), and digital innovations. The group reports a net cash position of EUR 8.8m and continues to invest in telemedicine platforms such as Telecan and Can Clinic. Cantourage views regulatory changes in Germany as an opportunity to further strengthen its market position. » Altro su finanzen.net